Kabra Drugs Ltd Share Price

0.82

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 30-Sep-2019 11-Sep-2019 - -
AGM 30/09/2019 In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we hereby inform you that the following businesses were transacted at the 30th Annual General Meeting of the Company held on Monday the 30th September 2019 at 03.00 P.M. at Registered office of the company: 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2019 and Reports of the Directors and Auditors thereon. 2. Ordinary Resolution for re-appointment of M/s RISHI SEKHRI AND ASSOCIATES CHARTERED ACCOUNTANTS as a Statutory Auditor of the Company for period of 3 years till conclusion of Annual General Meeting held in year 2022. The above businesses were transacted and passed by the shareholders at Annual General Meeting. Details of voting results as required under Regulation 44(3) of Listing Regulations are being submitted separately. (As per BSE Announcement Dated on 30.09.2019) Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the voting results of the business transacted at the Annual General Meeting of the Company held on Monday, the 30th September 2019 at 03.00 p.m. at registered office of the company in the prescribed format. Kindly take note of the above. Thanking you (As Per BSE Announcement Dated on 01/10/2019)